Ranbaxy integration: Sun may drop some non-strategic units
Sun Pharma may discontinue certain non-strategic businesses as part of its integration process with Ranbaxy Laboratories, which it acquired in a USD 4 billion deal last year.
Nov 01, 2015, 10:58 AM IST